Literature DB >> 10946008

Phosphatidylinositol promotes cholesterol transport in vivo.

C J Stamler1, D Breznan, T A Neville, F J Viau, E Camlioglu, D L Sparks.   

Abstract

To examine the role that lipoprotein charge plays in cholesterol metabolism in vivo, we characterized the effects of an intravenous injection of 40 micromol of an uncharged phospholipid (phosphatidylcholine, PC) or an anionic phospholipid (phosphatidylinositol, PI) into fasted rabbits. PC injection had a negligible effect on lipoprotein charge and composition, similar to that observed in a saline-injected animal. In contrast, PI injection caused a significant increase in the net negative surface charge of all lipoproteins after only 10 min, followed by a gradual return to normal by 24 h. Lipoprotein compositional analysis showed that PI caused a significant increase of cholesteryl ester (CE) and cholesterol (FC) in the VLDL pool by 3 h, with no changes in VLDL-triglyceride content. While the bulk of the plasma CE was located in the HDL pool in the PC-injected animals, in the PI animals, VLDL became the major CE storage compartment. No major changes in the levels or composition of HDL or LDL were evident over the 24-h turnover period. Co-injection of [(3)H]FC revealed a 30-fold greater rate of clearance of the labeled cholesterol from the PI-injected rabbit plasma. In addition, the rate of cholesterol esterification by lecithin:cholesterol acyltransferase was almost completely inhibited in the PI animals. In summary, a bolus injection of PI into rabbits appears to enhance the mobilization of cellular sterol and promote a rapid clearance of both FC and CE from the plasma compartment. The data show that lipoprotein charge can affect cholesterol transport and that this process can be selectively manipulated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10946008

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  6 in total

1.  Arachidonic acid-modified lovastatin discoidal reconstituted high density lipoprotein markedly decreases the drug leakage during the remodeling behaviors induced by lecithin cholesterol acyltransferase.

Authors:  Hongliang He; Lisha Liu; Hui Bai; Ji Wang; Yan Zhang; Wenli Zhang; Mengyuan Zhang; Zimei Wu; Jianping Liu
Journal:  Pharm Res       Date:  2014-01-22       Impact factor: 4.200

2.  Modifications in lipoprotein surface charge alter cyclosporine A association with low-density lipoproteins.

Authors:  Kishor M Wasan; Olena Sivak
Journal:  Pharm Res       Date:  2003-01       Impact factor: 4.200

3.  Association of the endotoxin antagonist E5564 with high-density lipoproteins in vitro: dependence on low-density and triglyceride-rich lipoprotein concentrations.

Authors:  Kishor M Wasan; Olena Sivak; Richard A Cote; Aaron I MacInnes; Kathy D Boulanger; Melvyn Lynn; William J Christ; Lynn D Hawkins; Daniel P Rossignol
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

4.  A phospholipidomic analysis of all defined human plasma lipoproteins.

Authors:  Monireh Dashti; Willem Kulik; Frans Hoek; Enno C Veerman; Maikel P Peppelenbosch; Farhad Rezaee
Journal:  Sci Rep       Date:  2011-11-07       Impact factor: 4.379

Review 5.  Plastids of marine phytoplankton produce bioactive pigments and lipids.

Authors:  Parisa Heydarizadeh; Isabelle Poirier; Damien Loizeau; Lionel Ulmann; Virginie Mimouni; Benoît Schoefs; Martine Bertrand
Journal:  Mar Drugs       Date:  2013-09-09       Impact factor: 5.118

6.  Identification of lipid biomarker from serum in patients with chronic obstructive pulmonary disease.

Authors:  Ding Liu; Maureen Meister; Shiying Zhang; Chi-In Vong; Shuaishuai Wang; Ruixie Fang; Lei Li; Peng George Wang; Pierre Massion; Xiangming Ji
Journal:  Respir Res       Date:  2020-09-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.